// App-Quantinova.ai

EP786 : KTE-X19 VERSUS STANDARD OF CARE FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA PREVIOUSLY TREATED WITH BRUTON TYROSINE KINASE INHIBITORS: REAL-WORLD EVIDENCE FROM EUROPE

Researchers

Presenter

  • Georg Hess

Principal Investigators

  • Lucie Oberic

  • Eva Gine

  • Pier Luigi Zinzani

  • Kim Linton

  • Adam Vilmar

  • Mats Jerkeman

  • Jenny MH Chen

  • Anke Ohler

  • Stephan Stilgenbauer

  • Catherine Thieblemont

  • Jonathan Lambert

  • Vittorio Ruggero Zilioli

  • Juan Manuel Sancho

  • Luca Fischer

  • Sam Keeping

  • Julie E Park

  • Gregory A. Maglinte

  • Liliosa Nyamutswa

  • Rubina Siddiqi

  • John Reitan

  • Sally Wade

  • Gilles Salles

Medical Centers

  • Centre Hospitalo-Universitaire Lyon Sud, Lyon, France

  • GELTAMO, Institut Català d'Oncologia

  • Department of Hematology, Oncology and Pneumology, Comprehensive Cancer Center, University Medical School of the Johannes Gutenberg-University,Mainz,Germany

  • Kite Pharma,Santa Monica,United States

  • Hospital Doce de Octubre, Madrid, Spain

  • Consulting,Salt Lake City,United States

  • RJM Group, LLC,Crown Point,United States

  • Department of Internal Medicine III, Ulm University,Ulm,Germany

  • Odense University Hospital, Odense, Denmark

  • Wade Outcomes Research &amp

  • Dermatology Department, Hospital Clinic of Barcelona, Barcelona, Spain

  • The Christie Hospital, Manchester, United Kingdom

  • PRECISIONheor,Vancouver, BC,Canada

  • Université de Paris,Paris,France

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • Hospital Germans Trias i Pujol, Barcelona, Spain

  • Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

  • Service d'Hématologie,Toulouse,France

  • APHP, Hôpital Saint-Louis, Hemato-oncologie

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Lund University,Lund,Suécia

  • Medizinische Klinik III, LMU Klinikum,Munich,Germany

Locations

  • France

  • Germany

  • United States

  • Spain

  • Denmark

  • United Kingdom

  • Canada

  • Italy

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mantle cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Randomized

  • Observational

  • Multicenteric

  • Cohort

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved